Robert Serunjogi

A hospital-based birth defects surveillance system in Kampala, Uganda

Daniel Mumpe‐Mwanja, Linda Barlow‐Mosha, Dhelia Williamson et al. · BMC Pregnancy and Childbirth · 2019 · 59 citations · Full text

Public Health, Maternal Health, Obstetrics +17

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Pauline Amuge, Abbas Lugemwa, Ben Wynne et al. · The Lancet HIV · 2022 · 31 citations · Full text

Pharmacy, Infectious Diseases, Pediatrics +15

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Anna Turkova, Hylke Waalewijn, Man K. Chan et al. · The Lancet HIV · 2022 · 24 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Prevalence of neural tube defects, maternal <scp>HIV</scp> status, and antiretroviral therapy from a hospital‐based birth defect surveillance in Kampala, Uganda

Linda Barlow‐Mosha, Robert Serunjogi, Dennis Kalibbala et al. · Birth Defects Research · 2021 · 17 citations · Full text

Medicine, Maternal Health, Obstetrics +15

Comparative analysis of perinatal outcomes and birth defects amongst adolescent and older Ugandan mothers: evidence from a hospital-based surveillance database

Robert Serunjogi, Linda Barlow‐Mosha, Daniel Mumpe‐Mwanja et al. · Reproductive Health · 2021 · 16 citations · Full text

Public Health, Maternal Health, Obstetrics +17